Cagrilintide: The Long-Acting Second-Generation Amylin Analog Cagrilintide (also written as AM-833) is a second-generation amylin analog developed specifically to address pramlintide's short half-life
Symptoms often include: Constant fatigue, even with rest Brain fog and difficulty concentrating Sluggish metabolism and slow recovery after workouts Frequent illness or weakened immunity Early signs of aging like poor skin quality and low energy Instead of masking these issues, our therapies address them at the source, restoring balance and vitality from within
Enhances detoxification L-Glutathione enhances detoxification by binding to harmful toxins, heavy metals, and waste products, converting them into water-soluble compounds that can be easily excreted through urine or bile
Do not use during active cancer treatment
Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells
Some people may not be candidates so it is important to discuss your health history with your provider prior to receiving treatment